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Seasonal Influenza Vaccination Policies in the Eastern Mediterranean Region: 1 
Current State and the Way Forward 2 
 3 
Abstract 4 
Background: The World Health Organization recommends annual influenza vaccination 5 
especially in high-risk groups. Little is known about the adoption and implementation of 6 
influenza vaccination policies in the Eastern Mediterranean Region.  7 
Methods: A survey was distributed to the 22 EMR country representatives at the 8 
Ministries of Health between December 2016 and February 2017 to capture data on 9 
influenza immunization policies, recommendations, and practices in place. 10 
Results: Of the 20 Eastern Mediterranean Region member states that responded to the 11 
survey, fourteen reported having influenza immunization policies during the 2015/2016 12 
influenza season. All member states with an influenza immunization policy 13 
recommended vaccination for persons with chronic medical conditions, health-care 14 
workers, and pilgrims. However, two countries fell short of targeting pregnant women. 15 
Eight countries used the northern hemisphere formulation, one used the southern 16 
hemisphere formulation, and nine used both. Vaccination coverage was not monitored by 17 
all member states and for all target groups, yet reported coverage of a number of target 18 
groups (i.e. health-care workers, children) was generally low. Furthermore, data on the 19 
burden of influenza and vaccine protection was scarce in the region.  20 
Conclusions: The 2015/2016 survey permitted a regional assessment of national 21 
influenza immunization policies. Addressing disparities in influenza vaccine accessibility 22 
and strengthening surveillance systems may enhance influenza vaccine introduction and 23 
use. 24 
Keywords: Influenza, vaccination, survey, policy, Eastern Mediterranean Region 25 
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1. Background 5 
 Seasonal influenza is an acute viral infection that affects people of all age groups 6 
worldwide. As per the World Health Organization (WHO) estimates, influenza viruses 7 
infect between 5%–15% of the global population, annually causing an estimated 3-5 8 
million severe cases and up to 650,000 respiratory deaths [1]. Annual seasonal epidemics 9 
have also been associated with significant health care costs and productivity losses [2,3].  10 
 Annual vaccination is the cornerstone for preventing infection, severe disease, and 11 
mortality due to influenza [4]. Vaccination against influenza is particularly important for 12 
individuals at high risk for disease complications and those caring for them., The WHO 13 
recommends annual influenza vaccination for pregnant women at any stage of pregnancy, 14 
children aged between 6 months to 5 years, elderly individuals (> 65-year-old), 15 
individuals with chronic medical conditions, and health-care workers (HCWs) [1]. In 16 
countries where influenza vaccination programmes are still at their early stages or not 17 
well developed, the WHO recommends prioritizing vaccination for pregnant women, 18 
whereas other risk groups are not ranked by priority [5]. On the other hand, the United 19 
States Centre for Disease Control and Prevention (CDC) has taken a more universal 20 
approach recommending the use of annual influenza vaccine for all persons aged ≥6 21 
months [6]. However, during a vaccine shortage, the CDC recommends that vaccination 22 
efforts be focused on high-risk groups only with no order by priority [6].  23 
 The WHO Eastern Mediterranean Region (EMR), which consists of 22 member 24 
states (Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, 25 
Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab 26 
Republic, Tunisia, United Arab Emirates (UAE), and Yemen) is home for nearly 10% of 27 
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the world’s population. However, the region’s share of influenza vaccines is roughly 1 
2.2% of the globally distributed doses [7]. Noteworthy, the EMR falls on a number of 2 
migratory birds’ flyways and is thus at risk for the emergence of novel influenza viruses 3 
[8]. Therefore, we undertook a survey to assess the adoption and implementation of 4 
influenza vaccination policies in the EMR to provide the data needed for evaluating and 5 
developing guidelines for influenza prevention with the goal of enhancing vaccination 6 
coverage. 7 
2. Method 8 
 The survey consisted of a 38-item questionnaire that was developed based on 9 
available relevant literature pertaining to influenza vaccination. The self-administered 10 
survey was distributed by email to the country representatives between December 2016 11 
and February 2017. The survey included questions on: mechanisms in place to monitor 12 
influenza vaccination coverage; vaccination coverage; existence of national 13 
recommendations for vaccination; and planned policies with regard to the national 14 
influenza immunization programme. 15 
3. Results 16 
Response rate 17 
In total, 20countries from across the WHO EMR completed the questionnaire 18 
resulting in a response rate of 90.9%. Responses were not received from Bahrain and 19 
Djibouti. 20 
Seasonal influenza vaccination policies 21 
Among the 20 countries for which the data were available, fourteen (70%) 22 
reported having seasonal influenza vaccination policies at the time surveyed (Egypt, Iran, 23 
Iraq, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Syria, 24 
Tunisia, and UAE). Of the above member states, five reported including the influenza 25 
vaccine in their national immunization program (Iran, Libya, Qatar, Syria, and Tunisia). 26 
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Morocco and Somalia, on the other hand, reported having plans regarding the 1 
implementation of official influenza vaccination policies in the next 5 years. 2 
Seasonal influenza surveillance for the 2015/2016 season 3 
 Of the 20 member states, seventeen (85%) reported having active influenza 4 
surveillance systems (Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, 5 
Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Sudan, Syria, Tunisia, and Yemen). All 6 
but one member state (Pakistan) reported using existing surveillance systems to guide 7 
policymakers and to help ensure well-informed policy decisions. 8 
 While mortality surveillance data for influenza were reportedly amassed by 16 9 
(80%) countries (Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Libya, Morocco, Oman, 10 
Palestine, Saudi Arabia, Sudan, Syria, Tunisia, UAE, and Yemen), only ten provided 11 
mortality rates (Egypt, Iran, Iraq, Jordan, Kuwait, Morocco, Oman, Syria, Tunisia, and 12 
Yemen). These ranged from 0% in Jordan to 15% in Morocco during the 2015/2016 13 
season. Fifteen (75%) countries also reported collecting data on influenza-associated 14 
hospitalizations (Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Morocco, Oman, 15 
Pakistan, Palestine, Saudi Arabia, Syria, Tunisia, UAE, and Yemen), yet only nine 16 
provided data on hospitalization rates (Egypt, Iran, Iraq, Jordan, Morocco, Oman, Syria, 17 
Tunisia, and Yemen). Hospitalization rates ranged from 0.004% in Iran to 21.7% in Iraq. 18 
Influenza vaccine recommendations 19 
i. Children 20 
 Among the countries having an influenza vaccination policy during the 2015/2016 21 
season, two countries, Libya and Qatar, included seasonal influenza vaccine in the 22 
childhood immunization schedule. Qatar targeted children <5 years of age. No 23 
specific age group was provided by Libya. 24 
ii. Adults 25 
 Four member states had influenza vaccination recommendations for adults during 26 
2015/2016. Countries recommending vaccination against influenza for adults were: 27 
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Oman, Qatar, Syria, and UAE. Oman and Qatar provided information on the age 1 
groups targeted, indicating that influenza vaccination was recommended for persons 2 
>60 years of age. 3 
iii. Chronic illnesses 4 
 All member states with recommendations for influenza vaccination recommended 5 
the influenza vaccine for persons with chronic illnesses (e.g. diabetes, asthma, renal 6 
disease, etc.) (Table 1). All but two countries, Jordan and Lebanon, recommended 7 
influenza vaccination for persons with immunological disorders and/or HIV/AIDS. 8 
Ten countries recommended vaccination for individuals with morbid obesity (Egypt, 9 
Iran, Iraq, Kuwait, Libya, Palestine, Saudi Arabia, Syria, Tunisia, and UAE), and 10 
nine recommended vaccination for those with spinal cord injuries and disorders that 11 
can result in pulmonary impairments and respiratory illness complications (Iran, Iraq, 12 
Kuwait, Libya, Palestine, Qatar, Saudi Arabia, Syria, and Tunisia). However, only 13 
five countries recommended vaccination for individuals on long-term aspirin use 14 
(Iraq, Kuwait, Lebanon, Qatar, and Saudi Arabia). 15 
iv. Pregnant women 16 
 Annual vaccination of pregnant women was recommended by all member states 17 
where an influenza vaccination policy exists, except Egypt and Lebanon, which had 18 
no specific recommendation for this group (Table 2). On the other hand, only Iraq, 19 
Kuwait, and Libya recommended maternal influenza vaccination during the early 20 
postpartum period. 21 
v. HCWs 22 
 All member states with an influenza vaccination policy had recommendations for 23 
vaccination of hospital personnel against influenza during the 2015/2016 season 24 
(Table 3). All but two member states (Lebanon and Syria) also recommended 25 
influenza vaccination for laboratory workers. Furthermore, eleven countries 26 
recommended seasonal influenza vaccination for persons working at long-term care 27 
facilities (Egypt, Iran, Iraq, Jordan, Kuwait, Libya, Oman, Palestine, Qatar, Saudi 28 
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Arabia, and UAE), and ten countries recommended vaccination for persons working 1 
at out-patient care clinics (Egypt, Iraq, Jordan, Kuwait, Libya, Oman, Palestine, 2 
Qatar, Saudi Arabia, and UAE). 3 
vi. Occupational groups (non-health care settings) 4 
 A smaller number of countries reported having influenza vaccine recommendations 5 
for one or more occupational groups (Table 4). Eleven member states recommended 6 
influenza vaccination for investigators of human influenza outbreaks (Egypt, Iran, 7 
Iraq, Jordan, Kuwait, Libya, Palestine, Qatar, Saudi Arabia, Syria, and Tunisia), yet 8 
only seven recommended vaccination for investigators of animal influenza outbreaks 9 
(Egypt, Iran, Iraq, Libya, Qatar, Saudi Arabia, and Tunisia). Furthermore, seven 10 
countries recommended seasonal influenza vaccination for airline crew members 11 
(Egypt, Iran, Iraq, Kuwait, Qatar, Tunisia, and UAE). For essential and emergency 12 
services (e.g. police, fire, and rescue staff), vaccination was recommended by six 13 
countries (Iran, Iraq, Kuwait, Libya, Tunisia, and UAE). Likewise, vaccination of 14 
military personnel was also recommended by six countries (Iran, Iraq, Kuwait, 15 
Libya, Oman, and Tunisia). Egypt, Iran, Iraq, Libya, and Tunisia had 16 
recommendations in place for persons working in the animal sector. Iraq was the 17 
only country in the region that had recommendations for families raising pigs, 18 
poultry, and/or waterfowl. 19 
vii. Other risk groups 20 
 Eight countries recommended seasonal influenza vaccination for persons living at 21 
long-term care facilities (e.g. nursing homes and other chronic-care facilities) (Iran, 22 
Iraq, Jordan, Kuwait, Libya, Palestine, Qatar, and Tunisia) (Table 5). Furthermore, 23 
four countries had influenza vaccination recommendations for all household 24 
members and caregivers of children younger than 5 years of age and persons aged 50 25 
years and older (Kuwait, Libya, Tunisia, and UAE). In addition, six countries had 26 
recommendations for all household contacts of persons at high risk for influenza 27 
complications (e.g. individuals with chronic medical conditions; the 28 
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immunosuppressed; the elderly; children aged <6 months i.e. cocooning strategy) 1 
(Iran, Kuwait, Libya, Syria, Tunisia, and UAE). 2 
viii. Pilgrims, expatriates, and refugees 3 
 Annual influenza vaccination of pilgrims was recommended by all member states 4 
with an influenza vaccination policy (Table 6). On the other hand, only five countries 5 
recommended influenza vaccination for refugees (Iraq, Kuwait, Libya, Syria, and 6 
Tunisia), and none recommended vaccination for expatriates. 7 
Vaccination monitoring and coverage 8 
 Six countries reported data on influenza vaccination coverage among high-risk 9 
groups during the 2015/2016 season. These were Egypt, Jordan, Kuwait, Morocco, 10 
Oman, and Saudi Arabia. Kuwait was the only country in the Region that provided 11 
coverage data for children >5 years of age, reporting a vaccination rate of only 2%. Data 12 
on vaccination coverage for pregnant women was also reported by one country (Oman), 13 
where the vaccination rate was 90%. Three countries, on the other hand, provided 14 
information on coverage for persons with specific illnesses; vaccination uptake in this 15 
target group ranged from 2% for non-communicable disease (NCD) patients in Kuwait to 16 
>70% for high-risk patients in Saudi Arabia. Furthermore, information on coverage 17 
among HCWs was provided by six countries and ranged from 39% in Kuwait to 100% in 18 
Egypt. Finally, three of the 14 member states recommending influenza vaccination for 19 
pilgrims in 2015/2016 reported data on coverage; vaccination coverage was 100% in all 20 
the three countries. 21 
Formulation and type of seasonal influenza vaccine 22 
 Eighteen countries provided information on vaccine formulation used, and of 23 
these, eight used the northern hemisphere formulation (Iran, Jordan, Lebanon, Morocco, 24 
Pakistan, Palestine, Syria, and Tunisia), one used the southern hemisphere formulation 25 
(Sudan), and nine used both formulations (Egypt, Iraq, Kuwait, Libya, Oman, Qatar, 26 
Saudi Arabia, UAE, and Yemen). 27 
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Seventeen countries, on the other hand, provided information on the type(s) of 1 
influenza vaccine licensed for use. Thirteen (76.4%) countries reported using inactivated 2 
trivalent influenza vaccines (Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, 3 
Oman, Pakistan, Qatar, Saudi Arabia, Syria, and Tunisia), three (17.6%) reported using 4 
inactivated quadrivalent influenza vaccines (Palestine, Qatar, and Tunisia), and one 5 
(7.6%) reported using the high-dose, inactivated, trivalent influenza vaccine (Libya). 6 
Sudan (7.6%) was the only country in the Region that used the live-attenuated trivalent 7 
influenza vaccine. 8 
Seasonal influenza vaccine providers and principal outlets for vaccination 9 
 Seventeen countries reported data on seasonal influenza vaccine providers and 10 
principal outlets for administration. Influenza vaccine was available solely through the 11 
public sector in four (20%) countries (Iran, Iraq, Sudan, and Tunisia). In the remaining 13 12 
(65%), influenza vaccine was available through both the public and the private sectors 13 
(Egypt, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, 14 
Saudi Arabia, Syria, and UAE). 15 
 The principal outlets for seasonal influenza vaccination reported by 14 (70%) 16 
countries were primary health care centers, hospitals, and out-patient care clinics (Egypt, 17 
Iran Iraq, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Syria, 18 
Tunisia, and UAE). Furthermore, seven (35%) countries reported providing influenza 19 
vaccines through community pharmacies, albeit to a lesser extent than hospitals and 20 
clinics (Egypt, Lebanon, Morocco, Oman, Pakistan, Palestine, and Syria). Occupational 21 
health services and schools, on the other hand, were reported to be the least common 22 
outlets for the administration of seasonal influenza vaccine. 23 
Promotion of seasonal influenza vaccination 24 
The majority of countries (n=14) reported the use of a wide range of media 25 
activities as tools to foster vaccination programs (Egypt, Iran, Iraq, Jordan, Kuwait, 26 
Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Tunisia, and UAE). The 27 
primary media activities used included television and radio advertising, leaflets, posters, 28 
and emails.  29 
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Future plans 1 
 Nine (45%) member states identified a number of planned strategies and 2 
operational policy changes needed to address the existing influenza vaccination 3 
impediments faced by most countries (Egypt, Kuwait, Libya, Morocco, Oman, Pakistan, 4 
Palestine, Qatar, Saudi Arabia, and UAE). Kuwait, for instance, has planned to 5 
implement regular influenza immunization campaigns for high-risk groups. Furthermore, 6 
Egypt has intended to expand the recommended groups for annual influenza 7 
immunization to include university students and vulnerable groups. Saudi Arabia has also 8 
prepared a plan to incorporate influenza vaccine in the national immunization schedule. 9 
Other plans included covering all risk groups in 2018 and progressing towards universal 10 
coverage by 2020 (Libya), adopting a recommendation of vaccination of people aged >60 11 
years and <2 years (Oman), implementing seasonal influenza vaccination policies 12 
targeting persons at high risk identified by the WHO  (Morocco), as well as strengthening 13 
existing surveillance systems (Palestine). Somalia expressed interest in implementing a 14 
vaccination policy for influenza but highlighted the need for guidance on development of 15 
the policy, surveillance systems for influenza, capacity building, purchase of vaccines, 16 
and vaccination activities in the country. 17 
4. Discussion 18 
 The 2015/2016 survey permitted a regional summary of the national influenza 19 
immunization policies. In general, our survey reveals an increase in the number of 20 
countries adopting an influenza immunization policy. Previously, a joint WHO/UNICEF 21 
report identified 12 countries in the EMR with seasonal influenza immunization policies 22 
in 2014 [9]. Whereas, our survey identified 14 EMR member states with influenza 23 
immunization policies in 2015/2016. Although trivial, the increased policy adoption 24 
reflects an improved awareness regarding influenza and the importance of vaccination in 25 
mitigating its burden. The findings provide essential information on the aspects that are 26 
critical for improving and strengthening the influenza vaccination policies and practices. 27 
 Surveillance of influenza is essential for the selection of appropriate vaccine 28 
strains and rapid detection of novel subtypes in humans [10]. Local surveillance data 29 
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provides country-specific information on the time and type of circulating influenza 1 
strains, which enables an informed-decision on the choice of the vaccine formulation to 2 
use. Local morbidity and mortality data are also required to provide a more complete 3 
picture of the burden of disease, which, in turn, is critical for the appreciation of threat of 4 
influenza to public health. This also provides evidence-based data needed for advocacy 5 
and assists in the development and updates of the prevention, control, and mitigation 6 
policies for influenza [10]. Seventeen out of the 22 EMR countries reported conducting 7 
surveillance for influenza. In fact, sixteen national laboratories in 15 countries are 8 
currently designated as National Influenza Centres, thirteen of which are tasked with 9 
detecting and isolating influenza [11]. Representative specimens are periodically shipped 10 
to the WHO collaborating centers for further analysis which provides data for vaccine 11 
strain selection. The number of influenza specimens reported to FluNet from participating 12 
centres in the EMR increased from 32,345 in 2011 to 66,000 in 2015 [11]. Currently, 13 
either one or both, the Northern and Southern Hemisphere vaccine formulations, are in 14 
use in the EMR countries. The increase in the availability of the local ERM influenza 15 
data will help optimize the recommendations for vaccine formulations in the EMR. 16 
 Seasonal influenza is a substantial cause of severe illness and hospitalization 17 
among infants younger than six months of age [12]. Studies found that, in many cases, 18 
the rate of hospitalization of children aged <6 months is three times that of children in the 19 
subsequent age group [12]. However, prevention of flu in this age group is problematic 20 
due to the absence of an approved vaccine, which, in turn, highlights the crucial need for 21 
other preventive strategies [12]. There is strong evidence to suggest that vaccinating 22 
pregnant women protects their newborn children for up to 6 months after they are born 23 
[13]. In fact, giving influenza vaccine to pregnant women was 91.5% effective in 24 
preventing hospitalization of infants due to influenza[14].Worth mentioning, not only 25 
does vaccinating pregnant women protect infants, but it also  prevents influenza infection 26 
and its dramatic effects during pregnancy, ranging from miscarriages, to preterm 27 
deliveries and a high maternal mortality rate [13,15,16]. Nonetheless, influenza 28 
vaccination policies in two countries in the region fell short of recommending maternal 29 
influenza vaccination, and only one country reported on influenza vaccination rates 30 
within this population. In addition to vaccinating pregnant women, the American 31 
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Academy of Pediatrics and the Centers for Disease and Control Prevention recommend 1 
“cocooning” as a method to protect young infants from seasonal influenza by ensuring all 2 
family members and close contacts receive the vaccine [17,18]. Despite this, only six 3 
countries recommended vaccination for household contacts and caregivers of children 4 
aged <6 months in the EMR, and none reported on influenza vaccination rates within this 5 
group. Therefore, evidence-based data on influenza outcomes in infants in the EMR is 6 
critically needed to emphasize on the importance of this prevention strategy.  7 
 Certain avian influenza viruses are potential zoonotic disease agents that may be 8 
transmitted from infected poultry to humans [19]. As such, poultry workers and 9 
veterinarians have an occupational risk of exposure to avian influenza viruses [19]. Five 10 
countries (Egypt, Iran, Iraq, Libya, and Tunisia) in the EMR had recommendations in 11 
place for persons working in the animal sector, all of which have experienced outbreaks 12 
of avian influenza) [20–24]. In particular, cases of human illnesses with H5N1 virus 13 
infection were detected in Egypt every year from 2006 to 2016 [25–28]. During the ten 14 
year period, a total of 363 human cases with influenza (H5N1) virus infection, including 15 
116 deaths, were reported in Egypt [29]. Nonetheless, the rational for vaccinating poultry 16 
workers with human influenza vaccine is not clear since there is no evidence that these 17 
vaccines protect against heterotypic avian influenza viruses [30]. One reason would be 18 
that vaccination of this group against human influenza can reduce the potential for an 19 
infection with a human virus, thus, minimizing the chance for a co-infection with an 20 
avian virus and the possibility of a subsequent reassortment event to occur between these 21 
viruses [31]. 22 
 As the world’s largest mass movement and gathering of people, the annual Hajj 23 
pilgrimage to Mecca creates an optimal environment for the spread of respiratory 24 
infections including influenza [32–34]. Nearly 40% of pilgrims suffer from respiratory 25 
symptoms during Hajj, with influenza virus being one of the most common etiologies 26 
[33,35,36]. The Ministry of Health (MOH) of Saudi Arabia recommends that all pilgrims, 27 
particularly those at increased risk of severe influenza disease including pregnant women, 28 
receive the most recent influenza vaccine before departing for the Hajj [37,38]. In 29 
accordance with the Saudi MOH recommendations, fourteen EMR member states 30 
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recommended pre-departure vaccination for all their pilgrims, yet only three reported on 1 
influenza vaccination rates among this group. On the positive side, universal coverage 2 
among this population was reported in all three EMR countries. These data suggest 3 
satisfactory compliance with the vaccine recommendation. Yet, in view of the limited 4 
number of countries reporting on influenza vaccination rates among pilgrims, the 5 
available data are not sufficiently representative. Furthermore, the reported data 6 
contradicted with those in the literature. For instance, one study found that only 19.4% of 7 
Egyptian pilgrims were found to be vaccinated against influenza in the 2015 Hajj season 8 
[39]. Another study by Memish et al. reported that only 22% of the Hajj pilgrims from 22 9 
countries (including some EMR countries) received the influenza vaccine in 2013[40]. 10 
 The accessibility of vaccines is one of the key barriers to improving vaccination 11 
rates, including for influenza [41]. Given their ubiquitous distribution, extended working 12 
hours, and walk-in policies, pharmacists are in an ideal position to provide influenza 13 
vaccines to the community and thus support the increase of immunization uptake [42,43]. 14 
For instance, a study by Steyer et al. demonstrated an increase in influenza immunization 15 
rates in the United States among persons aged 65 years and older following pharmacist 16 
involvement in influenza vaccination programmes [44]. This is consistent with data from 17 
Canada that showed an increase in influenza immunization rates when allowing 18 
pharmacists to administer influenza vaccines [44]. Of note, the impact appeared to be the 19 
greatest among persons aged 65 years and older [44]. This may relate to the fact that 20 
elderly present to pharmacies more frequently than younger people, giving more 21 
opportunity for pharmacists to engage in recommending vaccination to this age group. In 22 
the EMR, only seven countries reported providing influenza vaccines through community 23 
pharmacies, suggesting that the impact of allowing pharmacists to provide influenza 24 
vaccines on the uptake of seasonal influenza immunization is under appreciated in the 25 
region. Considering policies to expand the pharmacists’ role in immunization could 26 
improve the accessibility of influenza vaccination in the region and enhance vaccination 27 
rates. 28 
 In conclusion, despite widespread policy recommendations on influenza 29 
vaccination, attaining high coverage rates among the various populations including those 30 
13 
 
at risk continues to be a challenge in the EMR, as does the availability of influenza 1 
vaccines. In fact, in spite of the increase from previous years, the number of influenza 2 
vaccine doses distributed in the EMR in 2015 comprised only 2.2% of the global market 3 
[7]. Effective communication of influenza vaccination policies and strong advocacy 4 
initiatives are warranted to improve awareness of the public and health professionals 5 
about influenza and vaccines. In addition, equitable distribution and access to influenza 6 
vaccines will be critical for increasing uptake. Finally, encouraging and investing in 7 
influenza surveillance and research could be particularly valuable for controlling 8 
influenza in the EMR. Such research is important for making informed decisions on 9 
influenza vaccine introduction and expansion. 10 
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Table 1 1 
Seasonal influenza vaccine recommendations for clinical risk groups by EMR countries.  2 
1R, recommended 3 
2-, no data 4 
3NR, not recommended4UAE, United Arab Emirates 5 
 6 
  7 
 
 
Clinical risk groups 
Chronic 
medical 
condition 
Immunologic 
disorders HIV/AIDS 
Long-term 
aspirin use 
Any 
condition 
Extreme 
Obesity 
Residents of 
nursing home and 
other chronic care 
facilities 
 
Afghanistan no seasonal influenza vaccination policy 
Egypt  R1 R R NR - R NR 
Iran R R R - R R R 
Iraq R R R R R R R 
Jordan R  NR3 NR NR - NR NR 
Kuwait R R R R R R R 
Lebanon R NR NR NR NR      NR NR 
Libya R R R R R R R 
Morocco no seasonal influenza vaccination policy 
Oman R R R NR NR NR NR 
Pakistan no seasonal influenza vaccination policy 
Palestine R R R NR R R R 
Qatar R R R R R - R 
Saudi 
Arabia R R R R R R R 
Somalia no seasonal influenza vaccination policy 
Sudan no seasonal influenza vaccination policy 
Syria R R R - R R NR 
Tunisia R R -2 NR R R - 
UAE R R R - - R R 
Yemen no seasonal influenza vaccination policy 
18 
 
Table 2 1 
Seasonal influenza vaccine recommendations for women during pregnancy and early postpartum period by 2 
EMR countries. 3 
 4 
  5 
Country 
Risk factor 
Pregnant women Women up to two weeks post-
delivery 
Afghanistan no seasonal influenza vaccination policy 
Egypt NR NR 
Iran R - 
Iraq R R 
Jordan R  
Kuwait R R 
Lebanon NR NR 
Libya R R 
Morocco no seasonal influenza vaccination policy 
Oman R  
Pakistan no seasonal influenza vaccination policy 
Palestine R - 
Qatar R - 
Saudi Arabia R - 
Somalia no seasonal influenza vaccination policy 
Sudan no seasonal influenza vaccination policy 
Syria R NR 
Tunisia R NR 
UAE R - 
Yemen no seasonal influenza vaccination policy 
19 
 
Table 3 1 
Seasonal influenza vaccine recommendations for HCWs by EMR countries. 2 
Country Health-care setting Hospitals Out-patients care clinics Laboratories Long-term facilities 
Afghanistan no seasonal influenza vaccination policy 
Egypt R R R R 
Iran R - R R 
Iraq R R R R 
Jordan R R R R 
Kuwait R R R R 
Lebanon R NR NR NR 
Libya R R R R 
Morocco no seasonal influenza vaccination policy 
Oman R  R R 
Pakistan no seasonal influenza vaccination policy 
Palestine R R R R 
Qatar R R R R 
Saudi Arabia R R R R 
Somalia no seasonal influenza vaccination policy 
Sudan no seasonal influenza vaccination policy 
Syria R NR NR NR 
Tunisia R NR R NR 
UAE R R R R 
Yemen no seasonal influenza vaccination policy 
  3 
20 
 
Table 4 1 
Seasonal influenza vaccine recommendations for occupational groups by EMR countries. 2 
3 
Country 
Work setting  
Essential 
services 
(police, 
firemen, 
etc.) 
Military 
services 
Veterinary 
services 
Poultry 
industry 
Families 
that raise 
pigs, 
poultry 
or 
waterfowl 
Airline 
workers 
Investigators 
of human 
influenza 
outbreaks 
Investigators 
of animal 
influenza 
outbreaks 
Afghanistan no seasonal influenza vaccination policy  
Egypt - - R - - R R R 
Iran R R R R - R R R 
Iraq R R R R R R R R 
Jordan NR NR NR NR NR NR R - 
Kuwait R R NR NR NR R R NR 
Lebanon NR NR NR NR NR NR NR NR 
Libya R R R R - - R R 
Morocco no seasonal influenza vaccination policy  
Oman NR R NR NR NR NR NR NR 
Pakistan no seasonal influenza vaccination policy  
Palestine NR NR NR NR NR NR R NR 
Qatar - - - - - R R R 
Saudi 
Arabia NR NR NR NR NR NR R R 
Somalia no seasonal influenza vaccination policy  
Sudan no seasonal influenza vaccination policy  
Syria NR NR NR NR NR - R NR 
Tunisia R R R R NR R R R 
UAE R - - - - R - - 
Yemen no seasonal influenza vaccination policy  
21 
 
Table 5 1 
Seasonal influenza vaccine recommendations for residents of long-term facilities and household contacts of 2 
whom seasonal influenza vaccine is recommended by EMR countries. 3 
 4 
  5 
Country 
Risk group 
Residents of long-term care 
facilities (nursing homes and 
other chronic-care facilities) 
Household contacts and 
caregivers of children 
younger than 5 years and 
adults aged 50 years and 
older 
Household contacts of 
persons for whom 
vaccination is recommended 
Afghanistan no seasonal influenza vaccination policy 
Egypt NR NR - 
Iran R - R 
Iraq R NR NR 
Jordan R NR NR 
Kuwait R R R 
Lebanon NR NR NR 
Libya R R R 
Morocco no seasonal influenza vaccination policy 
Oman NR NR NR 
Pakistan no seasonal influenza vaccination policy 
Palestine R NR NR 
Qatar R - - 
Saudi 
Arabia NR NR NR 
Somalia no seasonal influenza vaccination policy 
Sudan no seasonal influenza vaccination policy 
Syria NR NR R 
Tunisia R R R 
UAE - R R 
Yemen no seasonal influenza vaccination policy 
22 
 
Table 6 1 
Seasonal influenza vaccine recommendations for pilgrims, expatriates, and/or refugees by EMR countries. 2 
 3 
 4 
Country Risk group Pilgrims Expatriates Refugees 
Afghanistan no seasonal influenza vaccination policy 
Egypt R NR  
Iran R NR NR 
Iraq R NR R 
Jordan R NR NR 
Kuwait R NR R 
Lebanon R NR NR 
Libya R - R 
Morocco no seasonal influenza vaccination policy 
Oman R NR NR 
Pakistan no seasonal influenza vaccination policy 
Palestine R NR NR 
Qatar R - - 
Saudi 
Arabia R NR NR 
Somalia no seasonal influenza vaccination policy 
Sudan no seasonal influenza vaccination policy 
Syria R - R 
Tunisia R NR R 
UAE R - - 
Yemen no seasonal influenza vaccination policy 
